BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31142339)

  • 1. MicroRNA based theranostics for brain cancer: basic principles.
    Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
    J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-based therapy for glioblastoma: Opportunities and challenges.
    Lei Q; Yang Y; Zhou W; Liu W; Li Y; Qi N; Li Q; Wen Z; Ding L; Huang X; Li Y; Wu J
    Eur J Pharmacol; 2023 Jan; 938():175388. PubMed ID: 36403686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
    Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
    Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA involvement in brain tumors: from bench to bedside.
    Nicoloso MS; Calin GA
    Brain Pathol; 2008 Jan; 18(1):122-9. PubMed ID: 18226107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
    Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
    Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA Multiplayers in glioma. From bench to bedside.
    Rolle K
    Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
    Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
    Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
    C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
    Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme.
    Mazurek M; Grochowski C; Litak J; Osuchowska I; Maciejewski R; Kamieniak P
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-Based Drugs for Brain Tumors.
    Anthiya S; Griveau A; Loussouarn C; Baril P; Garnett M; Issartel JP; Garcion E
    Trends Cancer; 2018 Mar; 4(3):222-238. PubMed ID: 29506672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA biomarkers in glioblastoma.
    Hermansen SK; Kristensen BW
    J Neurooncol; 2013 Aug; 114(1):13-23. PubMed ID: 23700324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review.
    Makowska M; Smolarz B; Romanowicz H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
    Choppavarapu L; Kandi SM
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.